Analyze Diet
Animals : an open access journal from MDPI2023; 13(15); 2514; doi: 10.3390/ani13152514

Insect Bite Hypersensitivity in Horses: Causes, Diagnosis, Scoring and New Therapies.

Abstract: Insect Bite Hypersensitivity (IBH, Queensland itch, sweet itch, equine summer eczema) is the most common pruritic disease of horses. It is most often caused by sensitivity to the saliva of spp. of biting midges; however, it can also be caused by hypersensitivity to other insect species. The prevalence of IBH in horses is reported to be as high as 60% in some parts of the world. Due to the severe pruritus and effects of secondary self-trauma, IBH has animal welfare concerns, and there is currently no cure. Management of this condition is life-long, time consuming and costly. New grading systems to document disease severity are being validated, which will allow the comparison of clinical trial results of new and existing therapies. Management involves the minimisation of insect bites by use of stabling, fans, rugs and repellents. Symptomatic therapy involves the administration of systemic or topical corticosteroids, systemic antihistamines, and creams and sprays to promote skin healing and decrease inflammation. New immune-mediated therapeutics including vaccines, in addition to desensitisation procedures, show promise at controlling hypersensitivity reactions. This article will review aetiologic agents, pathophysiology, scoring systems and current and new therapies.
Publication Date: 2023-08-04 PubMed ID: 37570323PubMed Central: PMC10416928DOI: 10.3390/ani13152514Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article broadly investigates the causes, diagnoses, scoring systems and current as well as new therapies for Insect Bite Hypersensitivity (IBH), a prevalent and severe discomfort-causing condition in horses with no known cure. It primarily happens due to horse’s sensitivity to the saliva of midges, albeit other insects can also induce hypersensitivity.

Understanding Insect Bite Hypersensitivity

  • Insect Bite Hypersensitivity (IBH), also known under several names like Queensland itch, sweet itch, and equine summer eczema, is identified as a prevalent pruritic (itching) condition in horses.
  • It is majorly caused due to sensitivity developed in response to the saliva of some species of biting midges, highlighting this condition’s hypersensitive nature. However, hypersensitivity reactions may also emerge from other insect species.
  • Up to 60% of horses in some parts of the world reportedly suffer from IBH, indicating its vast prevalence.
  • IBH poses considerable animal welfare concerns because of the intense itchiness it causes in horses, following the ensuing secondary self-trauma. Currently, no cure exists for it.

Management and Severity Scoring of IBH

  • The management of IBH is a challenging, expensive, and lifelong process. It primarily comprises preventative strategies that minimize insect bites, such as using fans, rugs, repellents, or keeping horses in stables.
  • Scientists are working to validate new grading systems to record the severity of IBH. These scoring systems would further pave the way to compare results from clinical trials investigating new and existing therapies.

Existing and Emerging Therapies

  • Existing symptomatic treatments entail the application of systemic or topical corticosteroids, systemic antihistamines, as well as various creams and sprays developed to promote skin healing and alleviate inflammation.
  • Future promising treatments are mostly focused on immunity. They include vaccines and desensitisation procedures intended to control hypersensitivity reactions in horses.

Overview of the Research Article

  • This paper delves into a comprehensive review of the causative agents, pathophysiology, and scoring systems, along with a critical evaluation of current and upcoming therapies for Insect Bite Hypersensitivity in horses.

Cite This Article

APA
Cox A, Stewart AJ. (2023). Insect Bite Hypersensitivity in Horses: Causes, Diagnosis, Scoring and New Therapies. Animals (Basel), 13(15), 2514. https://doi.org/10.3390/ani13152514

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 13
Issue: 15
PII: 2514

Researcher Affiliations

Cox, Abbey
  • School of Veterinary Science, University of Queensland Gatton, 5391 Warrego Highway, Gatton, QLD 4343, Australia.
Stewart, Allison J
  • School of Veterinary Science, University of Queensland Gatton, 5391 Warrego Highway, Gatton, QLD 4343, Australia.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 67 references
  1. Fadok VA. Update on equine allergies.. Vet Clin North Am Equine Pract 2013 Dec;29(3):541-50.
    doi: 10.1016/j.cveq.2013.08.005pubmed: 24267673google scholar: lookup
  2. Björnsdóttir S, Sigvaldadóttir J, Broström H, Langvad B, Sigurdsson A. Summer eczema in exported Icelandic horses: influence of environmental and genetic factors.. Acta Vet Scand 2006 May 26;48(1):3.
    doi: 10.1186/1751-0147-48-3pmc: PMC1513129pubmed: 16987399google scholar: lookup
  3. van Grevenhof EM, Ducro B, Heuven HC, Bijma P. Identification of environmental factors affecting the prevalence of insect bite hypersensitivity in Shetland ponies and Friesian horses in The Netherlands.. Equine Vet J 2007 Jan;39(1):69-73.
    doi: 10.2746/042516407X153020pubmed: 17228599google scholar: lookup
  4. Lomas HR, Robinson PA. A Pilot Qualitative Investigation of Stakeholders' Experiences and Opinions of Equine Insect Bite Hypersensitivity in England.. Vet Sci 2018 Jan 9;5(1).
    doi: 10.3390/vetsci5010003pmc: PMC5876561pubmed: 29315275google scholar: lookup
  5. Rashmir-Raven AM. Disorders of the Skin. In: Reed S.M., Bayly W.M., Sellon D.C., editors. Equine Internal Medicine. Elsevier; Philadelphia, PA, USA: 2017. pp. 1159–1216.
  6. Rashmir-Raven AM. A review of physical urticarias in the horse. Equine Vet. Educ. 2019;31:195–197.
    doi: 10.1111/eve.12851google scholar: lookup
  7. Knottenbelt DC. Pascoe’s Principles & Practice of Equine Dermatology. Saunders; London, UK: 2014.
  8. McAuliffe SB. Knottenbelt and Pascoe’s Color Atlas of Diseases and Disorders of the Horse E-Book. Elsevier–Health Sciences Division; Saint Louis, MO, USA: 2014.
  9. Riek RF. Studies On Allergic Dermatitis (“Queensland Itch”) Of The Horse: I-Description, Distribution, Symptoms And Pathology. Aust. Vet. J. 1953;29:177–184.
  10. Torsteinsdottir S, Scheidegger S, Baselgia S, Jonsdottir S, Svansson V, Björnsdottir S, Marti E. A prospective study on insect bite hypersensitivity in horses exported from Iceland into Switzerland.. Acta Vet Scand 2018 Nov 3;60(1):69.
    doi: 10.1186/s13028-018-0425-1pmc: PMC6215642pubmed: 30390694google scholar: lookup
  11. Sommer-Locher BV, Endriss V, Fromm E. Various Circumstances Regarding Initial Allergen Exposure and Their Influence on Development of Insect Bite Hypersensitivity in Horses. J. Equine Vet. Sci. 2012;32:158–163.
  12. Schaffartzik A, Hamza E, Janda J, Crameri R, Marti E, Rhyner C. Equine insect bite hypersensitivity: what do we know?. Vet Immunol Immunopathol 2012 Jun 30;147(3-4):113-26.
    doi: 10.1016/j.vetimm.2012.03.017pubmed: 22575371google scholar: lookup
  13. Miller JE, Mann S, Fettelschoss-Gabriel A, Wagner B. Comparison of three clinical scoring systems for Culicoides hypersensitivity in a herd of Icelandic horses.. Vet Dermatol 2019 Dec;30(6):536-e163.
    doi: 10.1111/vde.12784pubmed: 31441172google scholar: lookup
  14. Jonsdottir S, Svansson V, Stefansdottir SB, Mäntylä E, Marti E, Torsteinsdottir S. Oral administration of transgenic barley expressing a Culicoides allergen induces specific antibody response.. Equine Vet J 2017 Jul;49(4):512-518.
    doi: 10.1111/evj.12655pubmed: 27859584google scholar: lookup
  15. Fettelschoss-Gabriel A, Fettelschoss V, Thoms F, Giese C, Daniel M, Olomski F, Kamarachev J, Birkmann K, Bühler M, Kummer M, Zeltins A, Marti E, Kündig TM, Bachmann MF. Treating insect-bite hypersensitivity in horses with active vaccination against IL-5.. J Allergy Clin Immunol 2018 Oct;142(4):1194-1205.e3.
    doi: 10.1016/j.jaci.2018.01.041pubmed: 29627082google scholar: lookup
  16. Fettelschoss-Gabriel A, Fettelschoss V, Olomski F, Birkmann K, Thoms F, Bühler M, Kummer M, Zeltins A, Kündig TM, Bachmann MF. Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.. Allergy 2019 Mar;74(3):572-582.
    doi: 10.1111/all.13659pmc: PMC6587569pubmed: 30402930google scholar: lookup
  17. Olomski F, Fettelschoss V, Jonsdottir S, Birkmann K, Thoms F, Marti E, Bachmann MF, Kündig TM, Fettelschoss-Gabriel A. Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch.. Allergy 2020 Apr;75(4):862-871.
    doi: 10.1111/all.14145pmc: PMC7217000pubmed: 31816097google scholar: lookup
  18. Fettelschoss-Gabriel A, Birkmann K, Pantelyushin S, Kündig TM. Molecular mechanisms and treatment modalities in equine Culicoides hypersensitivity.. Vet J 2021 Oct;276:105741.
    doi: 10.1016/j.tvjl.2021.105741pubmed: 34416400google scholar: lookup
  19. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein.. J Immunol 1979 Dec;123(6):2925-7.
    doi: 10.4049/jimmunol.123.6.2925pubmed: 501097google scholar: lookup
  20. Tai PC, Hayes DJ, Clark JB, Spry CJ. Toxic effects of human eosinophil products on isolated rat heart cells in vitro.. Biochem J 1982 Apr 15;204(1):75-80.
    doi: 10.1042/bj2040075pmc: PMC1158317pubmed: 7115333google scholar: lookup
  21. Olsén L, Bondesson U, Broström H, Olsson U, Mazogi B, Sundqvist M, Tjälve H, Ingvast-Larsson C. Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity.. Vet J 2011 Mar;187(3):347-51.
    doi: 10.1016/j.tvjl.2009.12.030pubmed: 20097587google scholar: lookup
  22. Mitson-Salazar A, Prussin C. Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.. Front Med (Lausanne) 2017;4:165.
    doi: 10.3389/fmed.2017.00165pmc: PMC5635264pubmed: 29057225google scholar: lookup
  23. Jonsdottir S, Cvitas I, Svansson V, Fettelschloss-Gabriel A, Torsteinsdottir S, Marti E. New Strategies for Prevention and Treatment of Insect Bite Hypersensitivity in Horses. Curr. Dermatol. Rep. 2019;8:303–312.
  24. Heimann M, Janda J, Sigurdardottir OG, Svansson V, Klukowska J, von Tscharner C, Doherr M, Broström H, Andersson LS, Einarsson S, Marti E, Torsteinsdottir S. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells.. Vet Immunol Immunopathol 2011 Mar 15;140(1-2):63-74.
    doi: 10.1016/j.vetimm.2010.11.016pubmed: 21168921google scholar: lookup
  25. Wilson AD, Harwood LJ, Björnsdottir S, Marti E, Day MJ. Detection of IgG and IgE serum antibodies to Culicoides salivary gland antigens in horses with insect dermal hypersensitivity (sweet itch).. Equine Vet J 2001 Nov;33(7):707-13.
    doi: 10.2746/042516401776249363pubmed: 11770994google scholar: lookup
  26. Cvitas I, Oberhänsli S, Leeb T, Dettwiler M, Müller E, Bruggman R, Marti EI. Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity.. PLoS One 2020;15(4):e0232189.
  27. Cvitas I, Oberhaensli S, Leeb T, Marti E. Equine keratinocytes in the pathogenesis of insect bite hypersensitivity: Just another brick in the wall?. PLoS One 2022;17(8):e0266263.
  28. van der Meide NM, Meulenbroeks C, van Altena C, Schurink A, Ducro BJ, Wagner B, Leibold W, Rohwer J, Jacobs F, van Oldruitenborgh-Oosterbaan MM, Savelkoul HF, Tijhaar E. Culicoides obsoletus extract relevant for diagnostics of insect bite hypersensitivity in horses.. Vet Immunol Immunopathol 2012 Oct 15;149(3-4):245-54.
    doi: 10.1016/j.vetimm.2012.07.007pubmed: 22906994google scholar: lookup
  29. van der Meide NM, Savelkoul HF, Meulenbroeks C, Ducro BJ, Tijhaar E. Evaluation of a diagnostic ELISA for insect bite hypersensitivity in horses using recombinant Obsoletus complex allergens.. Vet J 2014 Apr;200(1):31-7.
    doi: 10.1016/j.tvjl.2013.12.004pubmed: 24703873google scholar: lookup
  30. Novotny EN, White SJ, Wilson AD, Stefánsdóttir SB, Tijhaar E, Jonsdóttir S, Frey R, Reiche D, Rose H, Rhyner C, Schüpbach-Regula G, Torsteinsdóttir S, Alcocer M, Marti E. Component-resolved microarray analysis of IgE sensitization profiles to Culicoides recombinant allergens in horses with insect bite hypersensitivity.. Allergy 2021 Apr;76(4):1147-1157.
    doi: 10.1111/all.14556pmc: PMC8246938pubmed: 32780483google scholar: lookup
  31. Shrestha M, Solé M, Ducro BJ, Sundquist M, Thomas R, Schurink A, Eriksson S, Lindgren G. Genome-wide association study for insect bite hypersensitivity susceptibility in horses revealed novel associated loci on chromosome 1.. J Anim Breed Genet 2020 Mar;137(2):223-233.
    doi: 10.1111/jbg.12436pubmed: 31489730google scholar: lookup
  32. Schurink A, Wolc A, Ducro BJ, Frankena K, Garrick DJ, Dekkers JC, van Arendonk JA. Genome-wide association study of insect bite hypersensitivity in two horse populations in the Netherlands.. Genet Sel Evol 2012 Oct 30;44(1):31.
    doi: 10.1186/1297-9686-44-31pmc: PMC3524047pubmed: 23110538google scholar: lookup
  33. Scott DW, Miller WH. Equine Dermatology. 2nd ed. Elsevier; Amsterdam, The Netherlands: Saunders; Maryland Heights, MO, USA: 2011.
  34. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus.. Br J Dermatol 2010 Mar;162(3):587-93.
  35. Martin SA, Brown TM, Fehnel S, Deal LS, Katz EG, Chiou CF. The atopic dermatitis itch scale: development of a new measure to assess pruritus in patients with atopic dermatitis.. J Dermatolog Treat 2020 Aug;31(5):484-490.
    doi: 10.1080/09546634.2020.1713971pubmed: 32037925google scholar: lookup
  36. Olivry T, Marsella R, Iwasaki T, Mueller R. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.. Vet Dermatol 2007 Apr;18(2):78-86.
  37. Olivry T, Mueller R, Nuttall T, Favrot C, Prélaud P. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.. Vet Dermatol 2008 Jun;19(3):115-9.
  38. Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, Hill PB. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.. Vet Dermatol 2014 Apr;25(2):77-85, e25.
    doi: 10.1111/vde.12107pubmed: 24461108google scholar: lookup
  39. Geiben T. Untersuchungen zum Sommerekzem Sowie zum Einfluss des Immunmodulators Baypamun N® auf die Typ I-Allergie der Pferde, in the University of Veterinary Medicine Hanover. The University of Veterinary Medicine Hanover; Hanover, Germany: 2003.
  40. Cox A, Wood K, Randhawa I, Kamphuis E, Medina-Torres CE, Stewart AJ. Analysis of Scoring Systems for the Diagnosis of Insect Bite Hypersensitivity in Horses [Abstract]. Proceedings of the Australian and New Zealand College of Veterinary Scientists Conference Week Gold Coast, Australia. 23–25 June 2022.
  41. Söderroos D, Ignell R, Haubro Andersen P, Bergvall K, Riihimäki M. The Effect of Insect Bite Hypersensitivity on Movement Activity and Behaviour of the Horse.. Animals (Basel) 2023 Apr 8;13(8).
    doi: 10.3390/ani13081283pmc: PMC10135092pubmed: 37106846google scholar: lookup
  42. Cox A, Wood K, Coleman G, Stewart AJ, Bertin FR, Owen H, Suen WW, Medina-Torres CE. Essential oil spray reduces clinical signs of insect bite hypersensitivity in horses.. Aust Vet J 2020 Aug;98(8):411-416.
    doi: 10.1111/avj.12963pubmed: 32761617google scholar: lookup
  43. Pilsworth RC, Knottenbelt DC. Equine insect hypersensitivity. Equine Vet. Ed. 2004;16:324–325.
  44. Smith BP. Large Animal Internal Medicine. Elsevier Mosby; Saint Louis, MO, USA: 2014.
  45. Clark BL, Stewart AJ, Kemp KL, Bamford NJ, Bertin FR. Evaluation of field-testing protocols to diagnose insulin dysregulation in ponies using a Bayesian approach.. Vet J 2023 Aug-Sep;298-299:106019.
    pubmed: 37536451doi: 10.1016/j.tvjl.2023.106019google scholar: lookup
  46. Grady JA, Davis EG, Kukanich B, Sherck AB. Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses.. Am J Vet Res 2010 Jul;71(7):831-9.
    doi: 10.2460/ajvr.71.7.831pubmed: 20594087google scholar: lookup
  47. Ginel PJ, Hernández E, Lucena R, Blanco B, Novales M, Mozos E. Allergen-specific immunotherapy in horses with insect bite hypersensitivity: a double-blind, randomized, placebo-controlled study.. Vet Dermatol 2014 Feb;25(1):29-e10.
    doi: 10.1111/vde.12092pubmed: 24267396google scholar: lookup
  48. Barbet JL, Bevier D, Greiner EC. Specific immunotherapy in the treatment of Culicoides hypersensitive horses: a double-blind study.. Equine Vet J 1990 Jul;22(4):232-5.
  49. Anderson GS, Belton P, Jahren E, Lange H, Kleider N. Immunotherapy trial for horses in British Columbia with Culicoides (Diptera:Ceratopogonidae) hypersensitivity.. J Med Entomol 1996 May;33(3):458-66.
    doi: 10.1093/jmedent/33.3.458pubmed: 8667395google scholar: lookup
  50. Birras J, White SJ, Jonsdottir S, Novotny EN, Ziegler A, Wilson AD, Frey R, Torsteinsdottir S, Alcocer M, Marti E. First clinical expression of equine insect bite hypersensitivity is associated with co-sensitization to multiple Culicoides allergens.. PLoS One 2021;16(11):e0257819.
  51. Jonsdottir S, Svansson V, Stefansdottir SB, Schüpbach G, Rhyner C, Marti E, Torsteinsdottir S. A preventive immunization approach against insect bite hypersensitivity: Intralymphatic injection with recombinant allergens in Alum or Alum and monophosphoryl lipid A.. Vet Immunol Immunopathol 2016 Apr;172:14-20.
    doi: 10.1016/j.vetimm.2016.02.017pubmed: 27032498google scholar: lookup
  52. Stefansdottir SB, Jonsdottir S, Kristjansdottir H, Svansson V, Marti E, Torsteinsdottir S. Establishment of a protocol for preventive vaccination against equine insect bite hypersensitivity.. Vet Immunol Immunopathol 2022 Nov;253:110502.
    doi: 10.1016/j.vetimm.2022.110502pubmed: 36272211google scholar: lookup
  53. Jonsdottir S, Stefansdottir SB, Kristinarson SB, Svansson V, Bjornsson JM, Runarsdottir A, Wagner B, Marti E, Torsteinsdottir S. Barley produced Culicoides allergens are suitable for monitoring the immune response of horses immunized with E. coli expressed allergens.. Vet Immunol Immunopathol 2018 Jul;201:32-37.
    doi: 10.1016/j.vetimm.2018.05.005pubmed: 29914679google scholar: lookup
  54. Rhiner T, Fettelschoss V, Schoster A, Birkmann K, Fettelschoss-Gabriel A. Targeting eosinophils by active vaccination against interleukin-5 reduces basophil counts in horses with insect bite hypersensitivity in the 2nd year of vaccination.. Vet J 2022 Oct;288:105896.
    doi: 10.1016/j.tvjl.2022.105896pubmed: 36126798google scholar: lookup
  55. Jonsdottir S, Fettelschoss V, Olomski F, Talker SC, Mirkovitch J, Rhiner T, Birkmann K, Thoms F, Wagner B, Bachmann MF, Kündig TM, Marti E, Fettelschoss-Gabriel A. Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses.. Vaccines (Basel) 2020 May 9;8(2).
    doi: 10.3390/vaccines8020213pmc: PMC7349629pubmed: 32397549google scholar: lookup
  56. Langreder N, Schäckermann D, Meier D, Becker M, Schubert M, Dübel S, Reinard T, Figge-Wegener S, Roßbach K, Bäumer W, Ladel S, Hust M. Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses.. Sci Rep 2023 Mar 10;13(1):4029.
    doi: 10.1038/s41598-023-31173-ypmc: PMC10000358pubmed: 36899044google scholar: lookup
  57. Huhmann R, Mueller RS. A cream containing omega-3-fatty acids, humectants and emollients as an aid in the treatment of equine Culicoides hypersensitivity.. Vet Dermatol 2019 Apr;30(2):155-e46.
    doi: 10.1111/vde.12728pubmed: 30729602google scholar: lookup
  58. Chen HC, Chang WT, Hseu YC, Chen HY, Chuang CH, Lin CC, Lee MS, Lin MK. Immunosuppressive Effect of Litsea c뺺 L. Essential Oil on Dendritic Cell and Contact Hypersensitivity Responses.. Int J Mol Sci 2016 Aug 12;17(8).
    doi: 10.3390/ijms17081319pmc: PMC5000716pubmed: 27529236google scholar: lookup
  59. Gibson DE, Moore GP, Pfaff JA. Camphor ingestion.. Am J Emerg Med 1989 Jan;7(1):41-3.
    doi: 10.1016/0735-6757(89)90083-1pubmed: 2643959google scholar: lookup
  60. Han X, Parker TL. Lemongrass (Cymbopogon flexuosus) essential oil demonstrated anti-inflammatory effect in pre-inflamed human dermal fibroblasts.. Biochim Open 2017 Jun;4:107-111.
  61. Ansari M, Vasudevan P, Tandon M, Razdan R. Larvicidal and mosquito repellent action of peppermint (Mentha piperita) oil. Bioresour. Technol. 2000;71:267–271.
  62. Baldacchino F, Tramut C, Salem A, Liénard E, Delétré E, Franc M, Martin T, Duvallet G, Jay-Robert P. The repellency of lemongrass oil against stable flies, tested using video tracking.. Parasite 2013;20:21.
    doi: 10.1051/parasite/2013021pmc: PMC3718533pubmed: 23759542google scholar: lookup
  63. Elsaie LT, El Mohsen AM, Ibrahim IM, Mohey-Eddin MH, Elsaie ML. Effectiveness of topical peppermint oil on symptomatic treatment of chronic pruritus.. Clin Cosmet Investig Dermatol 2016;9:333-338.
    doi: 10.2147/CCID.S116995pmc: PMC5066694pubmed: 27785084google scholar: lookup
  64. He JJ, Chen HM, Li CW, Wu DW, Wu XL, Shi SJ, Li YC, Chen JN, Su ZR, Lai XP. Experimental study on antinociceptive and anti-allergy effects of patchouli oil. J. Essent. Oil Res. 2013;25:488–496.
  65. Yoon SC, Je IG, Cui X, Park HR, Khang D, Park JS, Kim SH, Shin TY. Anti-allergic and anti-inflammatory effects of aqueous extract of Pogostemon cablin.. Int J Mol Med 2016 Jan;37(1):217-24.
    doi: 10.3892/ijmm.2015.2401pubmed: 26531835google scholar: lookup
  66. Gonzales AJ, Bowman JW, Fici GJ, Zhang M, Mann DW, Mitton-Fry M. Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.. J Vet Pharmacol Ther 2014 Aug;37(4):317-24.
    doi: 10.1111/jvp.12101pmc: PMC4265276pubmed: 24495176google scholar: lookup
  67. Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI, King VI, Tena JK, Stegemann MR. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.. Vet Dermatol 2013 Dec;24(6):587-97, e141-2.
    doi: 10.1111/vde.12088pmc: PMC4286885pubmed: 24581322google scholar: lookup

Citations

This article has been cited 0 times.